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Summary
In this study, it was aimed to determine whether there is a 
statistically signifi cant diff erence of sleep duration and sleep 
quality between non-CAD individuals from general popula-
tion and patients admitted in a third stage cardiology clinic 
with a diagnosis of CAD. Th is observational, descriptive study 
was carried out between January 1, 2018 and March 31, 2018 
with 150 non-CAD people from general population, and 150 
patients with CAD diagnosis admitted in a cardiology clinic. 
People under 18 years of age and those with sleep apnea syn-
drome, or other signifi cant medical conditions leading to sleep 
disturbance were excluded from the study. A questionnaire 
of socio-demographic characteristics and of the Pittsburgh 
Sleep Quality Scale (PSQS) was applied to the participating 
patients and control group by face-to-face interview method. 
Pittsburgh Sleep Quality Index (PSQI) and total sleep duration 
were determined according to the responses to the questions in 
the PSQS. Diff erences between the groups were investigated. 
In the study, the mean duration of sleep (hours) in the group 
with CAD, DM, HT, and HLwas found to be statistically 
signifi cantly lower than the non-CAD group. Th e mean total 
score of PSQS in the group with CAD, DM, HT, and HLwas 
found to be statistically signifi cantly higher than non-CAD 
group. No statistically signifi cant diff erence was observed be-
tween the mean duration of sleep and averages of PSQS total 
points of the smoking and non-smoking groups. Sleep quality 
and duration of sleep were found to be signifi cantly associated 
with diseases such as CAD, cardiovascular heart diseases and 
their risk factors such as DM, HT, HL. In this context, it is 
possible to determine the sleep quality and the duration of sleep 
easily in the outpatient clinic conditions using the PSQS in 
the practice of family medicine application. By specifying the 
measures to be taken in this direction, appropriate counselling 
services can be provided for people at risk.
Keywords: coronary artery disease, sleep duration, sleep qua-
lity, Pittsburgh Sleep Quality Scale
Rezumat
Relația calității și duratei somnului cu boala ischemică 
coronariană
Scopul acestui studiu a fost de a stabili dacă există o diferență 
statistic semnifi cativă între durata și calitatea somnului la 
indivizii care nu suferă de boală ischemică coronariană (BIC) 
din populația generală și la pacienții internați într-o clinică 
de cardiologie de nivelul trei cu un diagnostic de BIC. Acest 
studiu observațional, descriptiv a fost efectuat în perioada 1 
ianuarie 2018 – 31 martie 2018, incluzând 150 de persoane 
din populația generală care nu au BIC și 150 de pacienți cu 
diagnostic de BIC, internați într-o clinică de cardiologie. Au 
fost excluse din studiu persoanele sub 18 ani și cele cu sindrom 
de apnee în somn sau cu alte afecțiuni medicale semnifi cative, 
care conduc la tulburări de somn. Un chestionar cu privire la 
caracteristicile sociodemografi ce și la scala Pittsburgh de cali-
tate a somnului (PSQS) a fost aplicat pacienților-participanți 
și grupului de control prin metoda interviului față în față. 
Indicele Pittsburgh al calității somnului (PSQI) și durata totală 
a somnului au fost determinate în funcție de răspunsurile 
la întrebările din PSQS. Au fost evaluate diferențele dintre 
grupuri. În studiu, durata medie a somnului (ore) în grupul 
cu BIC, diabet zaharat (DZ), hipertensiune arterială (HTA) 
și hiperlipidemie (HL) a fost considerată statistic semnifi cativ 
mai mică decât în grupul fără BIC. Scorul mediu total al PSQS 
din grupul cu BIC, DZ, HTA și HL a fost constatat statistic 
semnifi cativ mai mare decât în grupul fără BIC. Nu a fost 
observată nicio diferență semnifi cativă statistic între durata 
medie a somnului și mediile punctelor totale PSQS la cei care 
fumează și la nefumători. S-a constatat că durata și calitatea 
somnului sunt asociate în mod semnifi cativ cu boli precum 
BIC, maladii cardiovasculare și factorii de risc ai acestora, 
cum ar fi  DM, HTA, HL. În acest context, este posibil să se 
determine cu ușurință calitatea somnului și durata somnului 
în condiții de ambulatoriu, folosind aplicația PSQS în practica 
medicinei de familie. Precizând măsurile care trebuie luate 
în această direcție, se pot oferi servicii de consiliere adecvate 
pentru persoanele cu risc.
Cuvinte-cheie: boală ischemică coronariană, durata som-
nului, calitatea somnului, scala Pittsburgh de calitate a 
somnului
Резюме 
Взаимосвязь качества и длительности сна с заболе-
ваниями коронарных артерий
Исследование было направлено на определение стати-
стически значимых различий продолжительности и 
качества сна между лицами, не страдающими ише-
мической болезнью сердца (ИБС) из общего населения, 
и пациентами, поступившими в кардиологическую 
клинику третьего уровня с диагнозом ИБС. Это описа-
тельное исследование, основанное на наблюдении, было 
проведено в период с 1 января 2018 года по 31 марта 
2018 года с участием 150 человек из общей популяции, 
не имеющих ИБС, и 150 пациентов с диагнозом ИБС, 
поступивших в кардиологическую клинику. Люди в воз-
расте до 18 лет и лица с синдромом апноэ во сне или 
другими серьезными заболеваниями, приводящими к 
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8нарушению сна, были исключены из исследования. Во-
просник социально-демографических характеристик и 
Питтсбургской шкалы качества сна (PSQS) был приме-
нен к участвующим пациентам и контрольной группе 
методом очного интервью. Питтсбургский индекс 
качества сна (PSQI) и общая продолжительность сна 
были определены в соответствии с ответами на вопро-
сы в PSQS. Были исследованы различия между группами. 
В исследовании средняя продолжительность сна (часы) 
в группе с ИБС, сахарным диабетом (СД), артериаль-
ной гипертензией (АГ) и гиперлипидемией (ГЛ) была 
статистически значимо ниже, чем в группе без ИБС. 
Средний общий балл PSQS в группе с ИБС, СД, АГ и ГЛ 
был статистически достоверно выше, чем в группе без 
ИБС. Статистически значимых различий между сред-
ней продолжительностью сна и средними значениями 
общего количества баллов PSQS в группах среди курящих 
и некурящих не наблюдалось. Было установлено, что 
качество и продолжительность сна в значительной 
степени связаны с такими заболеваниями, как ИБС, 
сердечно-сосудистые заболевания и такими факторами 
риска, как СД, АГ, ГЛ. В этом контексте можно легко 
определить качество сна и продолжительность сна в 
условиях поликлиники, используя PSQS в практике се-
мейной медицины. Определив меры, которые необходимо 
предпринять в этом направлении, людям, подверженным 
риску, могут быть предоставлены соответствующие 
консультативные услуги.
Ключевые слова: ишемическая болезнь сердца, продол-
жительность сна, качество сна, Питтсбургская шкала 
качества сна
Introduction
Today, cardiovascular diseases (CVDs) are still 
the leading cause of death both, in the world and 
Turkey. In the Turkish Adult Risk Factor (TARF) cohort 
study (1990-2016), coronary heart disease (CHD) has 
been reported to be the leading cause of death with 
the rate of 42% which is followed by cancer (24%), 
other causes (traffic accident, violence, suicide, 
pulmonary heart disease, diabetes mellitus (DM), 
chronic renal failure (CRF), Alzheimer’s disease, etc.) 
(22%), and cerebrovascular diseases (CVD) (12%), 
respectively. Turkey ranks first for women and second 
for men after Latvia considering the CHD-related 
mortality rates in the age group of 45–74 among 
the European countries with high coronary artery 
disease (CAD) mortality rates [1]. 
Age (≥45 in men and ≥55 or early menopause 
in women), family history, smoking, hypertension 
(HT) (blood pressure of ≥140/90 or use of anti-
hypertensive medication), hypercholesterolemia 
(total cholesterol of ≥200, low-density lipoprotein 
[LDL]-cholesterol of ≥130), low high-density lipopro-
tein (HDL)-cholesterol (<40 mg/dL), and DM can be 
listed as the most important risk factors for CHD [2]. 
The underlying causes of CVD, which have become 
epidemic all over the world, are atherogenesis and 
typically accompanying thrombosis [3]. The concept 
of risk factors for CVD is supported by an indepen-
dent study [4].
Sleep is a state of inactivity that allows the or-
ganism to rest, which is also a regeneration process 
that re-prepares the entire body for life. It is among 
the most basic and inevitable daily life activities 
affecting the quality of life and general health of 
people and has physiological, psychological and 
social dimensions [5]. Factors affecting sleep inclu-
de age [6], gender [7], health status (presence of 
any disease) [8], caffeine [9] and nicotine [10] con-
sumption, alcohol use [11], exercise [12], drug use 
[13], diet, lifestyle [14] and environmental factors. 
Sleep quality includes both quantitative parame-
ters such as sleep duration, latency, and number 
of awakenings and qualitative parameters such as 
sleep depth and sleep comfort. Sleep quality and 
sleep time can lead to CAD directly or indirectly by 
causing risk factors for CAD.
The aim of this study was to investigate any 
possible statistically significant difference between 
patients with CAD and healthy individuals in terms 
of sleep duration and sleep quality.
Material and method
This observational descriptive study included 
a total of 150 patients who were admitted to the 
Cardiology Clinic or Coronary Intensive Care Unit of 
Republic of Turkey Ministry of Health University of 
Health Sciences Istanbul Bağcılar Health Application 
and Research Center (SUAM) due to any CAD dia-
gnosis between January 1, 2018 and March 31, 2018. 
This study was approved by the ethics committee of 
Republic of Turkey Ministry of Health University of 
Health Sciences Istanbul Bağcılar SUAM on February 
2, 2018 with the decision no. 2018.02.1.02.015. Pati-
ents under the age of 18 and those who diagnosed 
with sleep apnoea syndrome or had other medical 
causes leading to sleep disturbance were excluded 
from the study. The control group consisted of 150 
individuals from the general population who were 
over 18 years of age and had no sleep apnoea syn-
drome, CAD, and other medical causes leading to 
sleep disturbance.
A questionnaire consisting of the Pittsburgh 
Sleep Quality Index (PSQI) and questions about so-
cio-demographic characteristics was applied to all 
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the study through a face-to-face interview method. 
Socio-demographic characteristics, age, gender, 
sociocultural status, socioeconomic status, marital 
status, presence of CAD, family history of CAD, histo-
ry of DM, HT or hyperlipidemia (HL), smoking history, 
and the number of cigarettes smoked per day for 
those with a smoking history were recorded for all 
patients and healthy individuals. Total sleep time 
(TST) and PSQI score were determined according 
to the answers given to the questions in the PSQI. 
The PSQI components, which were subjective sleep 
quality (component 1), sleep latency (component 
2), sleep duration (component 3), sleep efficiency 
(component 4), sleep disturbance (component 5), 
use of sleep medications (component 6), and day-
time dysfunction (component 7), were calculated for 
both groups separately. Patients with PSQI>5 were 
considered to have poor sleep quality and those with 
a daily total sleep time of <6 hours were considered 
to have a low sleep duration.
Statistical analysis was performed using Num-
ber Cruncher Statistical System (NCSS) 2007 Statis-
tical Software. Descriptive data were expressed as 
mean, standard deviation, frequency, and percen-
tage distribution. Shapiro-Wilk test was used to 
check the normality of variables. Independent t-test 
was used for the pairwise comparison of variables 
that were normally distributed whereas Mann Whit-
ney U test was used for the pairwise comparison of 
variables that were not normally distributed. Quali-
tative data were compared by using the chi-square 
test. Among the factors affecting CAD, logistic re-
gression analysis was performed to determine PSQI 
and TST levels. A p value of <0.05 was considered 
statistically significant.
Results
Socio-demographic characteristics of groups 
and the significance levels are shown in the table at 
the end of the article. 
Evaluation of study data in terms of sleep quali-
ty showed that the mean sleep duration (hours) was 
significantly lower in patients with CAD compared to 
the control group (p=0.0001). All of the seven com-
ponents in the PSQI were found to be significantly 
higher in patients with CAD compared to the control 
group. Total mean PSQI scores of CAD patients were 
found to be significantly higher than the control 
group (p=0.0001).
The mean sleep duration (hours) was found 
to be significantly lower in patients with DM com-
pared to those without DM (p=0.0001). All of the 
seven components in the PSQI were found to be 
significantly higher in patients with DM compared to 
those without DM. The total mean PSQI scores were 
found to be significantly higher in patients with DM 
compared to those without DM (p=0.0001).
The mean sleep duration (hours) was found to 
be significantly lower in patients with HT compared 
to those without HT (p=0.0001). All of the seven com-
ponents in the PSQI were found to be significantly 
higher in patients with HT compared to those witho-
ut HT. The total mean PSQI scores were found to be 
significantly higher in patients with HT compared to 
those without HT (p=0.0001).
The mean sleep duration (hours) was found to 
be significantly lower in patients with HL compared 
to those without HL (p=0.0001). The first six com-
ponents of the PSQI were found to be significantly 
higher in patients with HL compared to those witho-
ut HL. The total mean PSQI scores were found to be 
significantly higher in patients with HL compared to 
those without HL (p=0.0001).
Discussion
The incidence and prevalence of CHD increases 
with age (3) and men older than 45 years of age 
and women older than 55 years of age have a much 
higher CHD risk compared to others (4). In the pre-
sent study, the number of individuals aged 55–64 
years, 65–79 years, and >80 years was found to be 
significantly higher in the CAD group compared to 
the control group (p=0.0001).
In the study, the number of male patients in 
the CAD group was found to be significantly higher 
than in control group (p=0.0001). Men are more li-
kely to develop atherosclerosis than women if other 
risk factors are equal. Women are protected against 
advanced atherosclerosis causing disease until 
menopause. Myocardial infarction is rare in women 
in the perimenopause period unless predisposing 
conditions such as diabetes, HL or severe HT are 
present [15]. 
In the present study, the number of high 
school and university graduates in the CAD group 
was significantly lower than the control group 
(p=0.0001). There are studies in the literature 
that are compatible with our results. In a study 
by Falkstedt et al. [16], the relative risk of CHD has 
been reported to increase as the education level 
decreases among Swedish men. In another study 
by Gudmundsson et al. (1995) of Icelandic indivi-
duals, all the risk factors for CHD have been found 
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to increase in both genders among individuals with 
low education level. Gonzalez et al. [17] reported a 
negative correlation between education level and 
risk of ischemic heart disease. The findings reported 
by Tillmann et al. [18] support that higher education 
level is associated with a lower CHD risk.
In the present study, low socioeconomic status 
has been shown to be associated with CAD. Studies 
in the literature have shown that risk factors for 
CHD including obesity, DM, HT, and poor lipid pro-
file increase in connection with diet in individuals 
with low socioeconomic status. L. Navalpotro et al. 
[19] has reported that the prevalence of obesity is 
higher in regions with low socioeconomic status. 
WM.  Hoang et al. [21] found in their study that low 
and moderate socioeconomic status were important 
risk factors for the development of systemic HT in 
women. Similarly, in a study by Clark et al. [21], 
low socioeconomic status has been shown to be 
associated with great increases in CVD risk in both 
men and women. Z. Yu et al. [22] has reported that 
the prevalence of risk factors for CVD is higher in 
individuals with low socioeconomic status and the 
relationship between socioeconomic status and CVD 
has been further reported to be more consistent in 
women than in men.
The number of single patients in the CAD group 
was significantly lower than the control group in the 
present study (p=0.0001). However, there are many 
studies in the literature showing that CAD and CAD-
related mortality and morbidity are lower in married 
individuals [23, 24, 25]. The reason for the different 
results in the present study may be attributed to 
the fact that the number of samples is limited and 
the distribution of risk factors for CAD between age 
groups is different. 
In the Adult Treatment Panel III (ATP III) guide-
lines published by National Cholesterol Education 
Program (NCEP) in 2001 and Coronary Heart Disea-
se Prevention and Treatment Guidelines published 
by Turkish Society of Cardiology in 2002, risk 
factors for CAD have been reported to be HT, DM, 
HL, and family history of CAD [2, 26]. The results 
obtained from this study are compatible with 
both the NCEP ATP III guideline and information 
in the guideline published by the Turkish Society 
of Cardiology.
There was a significant difference between 
individuals with and without CAD in terms of both 
sleep duration and sleep quality (p<0.0001). In a 
meta-analysis by D. Wang et al. [27], a significant 
correlation was found between short and long sleep 
duration and increased risk of CHD. Compared to 
patients who slept seven hours a day, the CHD risk 
was reported to increase by 7% increase with every 
additional hour of sleep and by 11% with every hour 
by which sleep duration was reduced [27]. T. Chan-
dola et al. [28] reported that short sleep duration (≤6 
hours) significantly increased the risk of CHD among 
participants who reported sleep disturbances and 
they further reported that there was little evidence 
that short sleep duration increased CHD risk among 
participants who did not report any sleep disturbance. 
In a study by X.Q. Lao et al. [29], a positive correlation 
was reported between CHD risk and both short 
sleep duration and poor sleep quality. M Sharma et al. 
[30] found an independent correlation between 
CAD and both short sleep duration (<6 hours) and 
poor sleep quality (PSQI>5). A positive correlation 
between CAD and short sleep duration (<6 hours) 
and poor sleep quality (PSQI>5) was reported in In-
dian adults and short sleep duration and poor sleep 
quality were reported to be important modifiable 
risk factors for CAD in the Indian population [30]. In 
the present study, a significant difference was found 
between patients with and without DM in terms of 
both sleep duration and sleep quality (p<0.0001). 
Similar findings are available in the literature [31, 
32, 33, 34]. 
We found a significant difference between 
patients with and without HT in terms of both sleep 
duration and sleep quality (p<0.0001). The mean 
sleep duration (hours) was found to be significantly 
lower in patients with HT compared to those without 
HT (p=0.0001). Studies in the literature support the 
findings of the present study [35, 36, 37].
Conclusion
Considering the study data and literature re-
view, sleep duration and sleep quality can be said 
to have a significant correlation with CAD and risk 
factors for CAD such as DM, HT, and HL. Furthermore, 
sleep quality and duration are thought to be poorer 
in individuals with such diseases.
One of the aims of Family Medicine both all 
over the world and in Turkey is to reduce the inci-
dence of diseases such as CVD, CAD, DM, HT, and HL 
and to prevent the costs related to these diseases. 
Family Physicians can apply PSQI to the population 
dependent to them as a preventive medicine and 
easily obtain information about their patients’ sleep 
quality and sleep duration. 
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Socio-demographic characteristics of the individuals included in the study  and statistical significance levels
Parameters Items CAD (-) (n=150) CAD (+) (n=150) p
Age
18–44 Years 116 77.33% 12 8.00%
0.0001
45–54 Years 24 16.00% 36 24.00%
55–64 Years 6 4.00% 40 26.67%
65–79 Years 4 2.67% 58 38.67%
>80 Years 0 0.00% 4 2.67%
Gender
Male 59 39.33% 98 65.33%
0.0001
Female 91 60.67% 52 34.67%
Sociocultural status
Literacy 5 3.33% 32 21.33%
0.0001
Primary education 53 35.33% 95 63.33%
High school 34 22.67% 19 12.67%
University graduate 58 38.67% 4 2.67%
Socioeconomic status
<TRY 1,500.00 56 37.33% 104 69.33%
0.0001
TRY 1,501.00–3,000.00 39 26.00% 41 27.33%
TRY 3,001.00–5,000.00 38 25.33% 5 3.33%
TRY 5,001.00–7,500.00 9 6.00% 0 0.00%
>TRY 7,500.00 8 5.33% 0 0.00%
Marital status
Married 92 61.33% 144 96.00%
0.0001Single 57 38.00% 3 2.00%
Divorced-Widow 1 0.67% 3 2.00%
Family history
No 90 60.00% 55 36.67%
0.0001
Yes 60 40.00% 95 63.33%
Diabetes mellitus
No 141 94.00% 88 58.67%
0.0001
Yes 9 6.00% 62 41.33%
Hypertension
No 139 92.67% 57 38.00%
0.0001
Yes 11 7.33% 93 62.00%
Hyperlipidemia
No 137 91.33% 85 56.67%
0.0001
Yes 13 8.67% 65 43.33%
Cigarette smoking
No 102 68.00% 90 60.00%
0.149
Yes 48 32.00% 60 40.00%
Number of cigarettes
Non-smoker 102 68.00% 90 60.00%
0.025
1 small package/day 22 14.67% 17 11.33%
1 package or 2 packages/day 26 17.33% 37 24.67%
2 large packages/day 0 0.00% 6 4.00%
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